Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-02-02 Sale |
2021-02-02 9:19 pm |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
3,625 | $30.75 | $111,469 | 35,848 (Direct) |
View |
| 2021-02-02 Sale |
2021-02-02 9:18 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
25,000 | $30.75 | $768,750 | 471,667 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-07 6:30 pm |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
1,376 | $26.83 | $36,918 | 24,055 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-07 6:29 pm |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
6,876 | $26.83 | $184,483 | 87,819 (Direct) |
View |
| 2020-12-15 Sale |
2020-12-16 8:55 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
5,549 | $26.02 | $144,385 | 196,667 (Direct) |
View |
| 2020-12-02 Sale |
2020-12-04 7:00 pm |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
7,891 | $23.43 | $184,849 | 202,216 (Direct) |
View |
| 2020-11-24 Sale |
2020-11-25 7:00 pm |
Travere Therapeutics Inc. | RTRX | Clague Laura Chief Financial Officer |
7,500 | $23.29 | $174,675 | 19,473 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-17 9:00 pm |
Travere Therapeutics Inc. | RTRX | Clague Laura Chief Financial Officer |
7,500 | $23.98 | $179,813 | 19,473 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-17 9:00 pm |
Travere Therapeutics Inc. | RTRX | ROTE WILLIAM E. Senior Vice President, R&D |
2,500 | $23.96 | $59,900 | 24,086 (Direct) |
View |
| 2020-11-16 Sale |
2020-11-17 9:00 pm |
Travere Therapeutics Inc. | RTRX | REED ELIZABETH E SVP, GC & Corporate Secretary |
2,500 | $23.98 | $59,950 | 25,431 (Direct) |
View |
| 2020-11-13 Sale |
2020-11-13 9:26 pm |
Retrophin Inc. | RTRX | REED ELIZABETH E SVP, GC & Corporate Secretary |
2,500 | $23.62 | $59,046 | 27,931 (Direct) |
View |
| 2020-11-13 Sale |
2020-11-13 9:25 pm |
Retrophin Inc. | RTRX | ROTE WILLIAM E. Senior Vice President, R&D |
2,500 | $23.62 | $59,056 | 26,586 (Direct) |
View |
| 2020-11-13 Sale |
2020-11-13 9:24 pm |
Retrophin Inc. | RTRX | Clague Laura Chief Financial Officer |
7,500 | $23.61 | $177,071 | 26,973 (Direct) |
View |
| 2020-11-05 Sale |
2020-11-06 8:56 pm |
Retrophin Inc. | RTRX | ASELAGE STEVE Director |
23,125 | $22.81 | $527,525 | 213,107 (Direct) |
View |
| 2020-10-02 Sale |
2020-10-05 8:31 pm |
Retrophin Inc. | RTRX | Heerma Peter Chief Commercial Officer |
4,376 | $19.13 | $83,691 | 42,329 (Direct) |
View |
| 2020-09-23 Sale |
2020-09-23 8:00 pm |
Retrophin Inc. | RTRX | ROTE WILLIAM E. Senior Vice President, R&D |
1,500 | $18.48 | $27,720 | 24,086 (Direct) |
View |
| 2020-09-23 Sale |
2020-09-23 8:00 pm |
Retrophin Inc. | RTRX | REED ELIZABETH E SVP, GC & Corporate Secretary |
1,500 | $18.48 | $27,720 | 25,431 (Direct) |
View |
| 2020-09-23 Sale |
2020-09-23 8:00 pm |
Retrophin Inc. | RTRX | Rosenberg Noah L. Chief Medical Officer |
750 | $18.48 | $13,860 | 27,555 (Direct) |
View |
| 2020-09-23 Sale |
2020-09-23 8:00 pm |
Retrophin Inc. | RTRX | Clague Laura Chief Financial Officer |
1,500 | $18.48 | $27,720 | 19,473 (Direct) |
View |
| 2020-09-22 Sale |
2020-09-22 9:20 pm |
Retrophin Inc. | RTRX | ROTE WILLIAM E. Senior Vice President, R&D |
1,500 | $18.59 | $27,885 | 25,586 (Direct) |
View |
| 2020-09-22 Sale |
2020-09-22 9:20 pm |
Retrophin Inc. | RTRX | Rosenberg Noah L. Chief Medical Officer |
750 | $18.59 | $13,943 | 28,305 (Direct) |
View |
| 2020-09-22 Sale |
2020-09-22 9:18 pm |
Retrophin Inc. | RTRX | REED ELIZABETH E SVP, GC & Corporate Secretary |
1,500 | $18.59 | $27,885 | 26,931 (Direct) |
View |
| 2020-09-22 Sale |
2020-09-22 9:18 pm |
Retrophin Inc. | RTRX | Clague Laura Chief Financial Officer |
1,500 | $18.59 | $27,885 | 20,973 (Direct) |
View |
| 2020-09-21 Sale |
2020-09-22 9:15 pm |
Retrophin Inc. | RTRX | Dube Eric M Chief Executive Officer |
10,805 | $19.28 | $208,319 | 94,695 (Direct) |
View |
| 2020-08-05 Sale |
2020-08-06 4:07 pm |
Retrophin Inc. | RTRX | ASELAGE STEVE Director |
2,500 | $19.68 | $49,200 | 236,232 (Direct) |
View |
| 2020-07-28 Sale |
2020-07-30 7:48 pm |
Retrophin Inc. | RTRX | Rosenberg Noah L. Chief Medical Officer |
870 | $20.49 | $17,826 | 26,055 (Direct) |
View |
| 2020-06-25 Sale |
2020-06-29 9:02 pm |
Retrophin Inc. | RTRX | ASELAGE STEVE Director |
10,000 | $20 | $200,000 | 238,732 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-01-31 Option Award |
2021-02-02 9:19 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
5,000 | $0 | 35,848 (Direct) |
View |
| 2021-02-02 Exercise |
2021-02-02 9:18 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
25,000 | $10.09 | 471,667 (Direct) |
View |
| 2021-02-21 Exercise |
2021-02-02 9:18 pm |
N/A 2024-11-05 |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
25,000 | $0 | 471,667 (Direct) |
View |
| 2021-01-21 Option Award(A) |
2021-01-28 8:00 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
212,660 | $0 | 212,660 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 8:58 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | ROTE WILLIAM E. Senior Vice President, R&D |
72,500 | $0 | 97,082 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 8:57 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | Rosenberg Noah L. Chief Medical Officer |
72,500 | $0 | 100,220 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 8:56 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | REED ELIZABETH E SVP, GC & Corporate Secretary |
72,500 | $0 | 96,555 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 8:55 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | Heerma Peter Chief Commercial Officer |
72,500 | $0 | 115,720 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 8:55 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | Clague Laura Chief Financial Officer |
72,500 | $0 | 91,973 (Direct) |
View |
| 2021-01-21 Option Award |
2021-01-25 8:54 pm |
N/A 2031-01-20 |
Travere Therapeutics Inc. | TVTX | Dube Eric M Chief Executive Officer |
269,860 | $0 | 357,679 (Direct) |
View |
| 2020-11-19 Gift |
2020-12-04 7:00 pm |
N/A N/A |
Travere Therapeutics Inc. | TVTX | ASELAGE STEVE Director |
3,000 | $0 | 202,216 (Direct) |
View |
| 2020-11-23 Option Award |
2020-11-25 7:00 pm |
N/A N/A |
Travere Therapeutics Inc. | RTRX | Clague Laura Chief Financial Officer |
7,500 | $0 | 19,473 (Direct) |
View |
| 2020-11-11 Option Award |
2020-11-13 9:26 pm |
N/A N/A |
Retrophin Inc. | RTRX | REED ELIZABETH E SVP, GC & Corporate Secretary |
5,000 | $0 | 27,931 (Direct) |
View |
| 2020-11-11 Option Award |
2020-11-13 9:25 pm |
N/A N/A |
Retrophin Inc. | RTRX | ROTE WILLIAM E. Senior Vice President, R&D |
5,000 | $0 | 26,586 (Direct) |
View |
| 2020-11-11 Option Award |
2020-11-13 9:24 pm |
N/A N/A |
Retrophin Inc. | RTRX | Clague Laura Chief Financial Officer |
15,000 | $0 | 26,973 (Direct) |
View |
| 2020-09-18 Option Award |
2020-09-22 9:20 pm |
N/A N/A |
Retrophin Inc. | RTRX | ROTE WILLIAM E. Senior Vice President, R&D |
3,000 | $0 | 25,586 (Direct) |
View |
| 2020-09-18 Option Award |
2020-09-22 9:20 pm |
N/A N/A |
Retrophin Inc. | RTRX | Rosenberg Noah L. Chief Medical Officer |
3,000 | $0 | 28,305 (Direct) |
View |
| 2020-09-18 Option Award |
2020-09-22 9:18 pm |
N/A N/A |
Retrophin Inc. | RTRX | REED ELIZABETH E SVP, GC & Corporate Secretary |
3,000 | $0 | 26,931 (Direct) |
View |
| 2020-09-18 Option Award |
2020-09-22 9:18 pm |
N/A N/A |
Retrophin Inc. | RTRX | Clague Laura Chief Financial Officer |
3,000 | $0 | 20,973 (Direct) |
View |
| 2020-09-18 Option Award |
2020-09-22 9:15 pm |
N/A N/A |
Retrophin Inc. | RTRX | Dube Eric M Chief Executive Officer |
28,000 | $0 | 94,695 (Direct) |
View |